Guardant Health Inc at JPMorgan Healthcare Conference Transcript
All right. Good afternoon. Let's get started. I'm Julia Qin, lead analyst covering life science tools and diagnostics at JPMorgan. And it's my great pleasure to introduce you to our next company presentation by Guardant Health. And with that, let me turn it over to Helmy.
Thank you, Julia, and thank you, everyone, for joining us and your interest in Guardant Health. Please note our forward-looking statement.
I would like to start our presentation, as we always do, with a patient story. These stories are the fuel that drives our relentless work and our mission to conquer cancer with data. Kirk Smith was an avid runner and cyclist, did not smoke, ate well and was in great overall shape.
Yet in December of 2013, Kirk was diagnosed with Stage 3 lung cancer at just 51 years old. His oncologist ordered his first Guardant360 test in 2017, providing actionable insights that gave Kirk access to more targeted
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |